Co-Authors
This is a "connection" page, showing publications co-authored by Guillaume Martin-Blondel and François-Xavier Lescure.
Connection Strength
0.106
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy? J Neurol Neurosurg Psychiatry. 2018 10; 89(10):1125-1126.
Score: 0.047